EARNINGS PER SHARE - Schedule of Basic and Diluted Earnings (Loss) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		3 Months Ended						9 Months Ended
	Jun. 26, 2023	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Numerator:
Net income		$ 53,856	$ 53,043	$ 44,791	$ 56,302	$ 114,403	$ 39,208	$ 151,690	$ 209,913
Denominator:
Weighted average number of common shares outstanding (in shares)		170,636			178,826			172,490	179,956
Effect of dilutive securities (in shares)		1,305			1,702			1,358	1,330
Weighted average number of common shares outstanding, diluted (in shares)		171,941			180,528			173,848	181,286
Earnings per common share, basic
Earnings per common share, basic (in dollars per share)		$ 0.32			$ 0.31			$ 0.88	$ 1.17
Earnings per common share, diluted
Earnings per common share, diluted (in dollars per share)		$ 0.31			$ 0.31			$ 0.87	$ 1.16
Amedisys
Earnings per common share, diluted
Termination fee	$ 106,000								$ 62,800